Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.370
-0.030 (-2.14%)
Apr 29, 2025, 4:00 PM EDT - Market closed

Akari Therapeutics, Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
403018357171
Upgrade
Market Cap Growth
71.26%71.26%-49.58%-51.00%0.31%93.59%
Upgrade
Enterprise Value
402910275859
Upgrade
Last Close Price
1.371.223.129.4030.0037.00
Upgrade
PB Ratio
1.641.36-77.0219.5312.857.59
Upgrade
P/TBV Ratio
---19.7212.917.61
Upgrade
Debt / Equity Ratio
0.150.15----
Upgrade
Quick Ratio
0.130.130.841.101.542.69
Upgrade
Current Ratio
0.150.150.951.151.912.79
Upgrade
Return on Equity (ROE)
-179.92%-179.92%-1281.43%-483.23%-233.27%-363.75%
Upgrade
Return on Assets (ROA)
-37.89%-37.89%-115.51%-113.26%-81.96%-106.60%
Upgrade
Return on Capital (ROIC)
-82.38%-82.38%-1344.91%-392.89%-144.04%-239.31%
Upgrade
Earnings Yield
-50.03%-65.52%-56.74%-50.73%-24.40%-24.00%
Upgrade
FCF Yield
-31.73%-41.55%-93.17%-61.47%-26.40%-23.82%
Upgrade
Buyback Yield / Dilution
-144.03%-144.03%-56.79%-45.46%-35.87%-72.53%
Upgrade
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q